NCT07518043 2026-04-15
A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors
Shanghai Henlius Biotech
Phase 1 Not yet recruiting
Shanghai Henlius Biotech
CSPC Megalith Biopharmaceutical Co.,Ltd.
Pfizer
Shanghai Epiprobe Biotechnology Co., Ltd.